KMO and invasive breast carcinoma: Our study has shown that the 3HK-producing enzyme, KMO, is highly elevated in BrCa, especially in HER2-enriched BrCa tissue, concordant with the high serum level of 3HK detected in people with BrCa (Fig. 3a–c).